MedTrace Logo

The Acute Effect of Physical Exercise in Pregnancy

NCT06565182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-08-21

No results posted yet for this study

Summary

The goal of this crossover clinical trial is to investigate the acute physiological effect of exercise on the uterine and fetal blood flow in pregnancy. The main questions it aims to answer are:

* What is the acute physiological effect of exercise on the uterine and fetal blood flow in pregnancy?
* What is the acute physiological effect of continuous aerobic exercise versus resistance exercise on the uterine and fetal blood flow in pregnancy?
* What is the effect of physical activity levels on the uterine and fetal blood flow in pregnancy?

Researchers will compare the continuous aerobic exercise to the resistance exercise with a 3-6-week interval to examine the acute physiological effect on the uterine and fetal blood flow.

Participants will:

* Fill in a physical activity level questionnaire at baseline.
* Complete either continuous aerobic exercise or resistance exercise and take blood flow measurements.
* Complete the remaining type of exercise after a 3-6-week interval and take blood flow measurements.

Conditions

  • Pregnancy Related

Interventions

OTHER

Exercise

The intervention consists of two different types of moderate intensity exercise: Continuous aerobic and resistance exercise.

Sponsors & Collaborators

  • University Hospital, Antwerp

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2022-05-06
Completion
2022-05-26

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06565182 on ClinicalTrials.gov